These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
363 related items for PubMed ID: 9331078
41. Human papillomavirus: its identity and controversial role in oral oncogenesis, premalignant and malignant lesions (review). Campisi G, Panzarella V, Giuliani M, Lajolo C, Di Fede O, Falaschini S, Di Liberto C, Scully C, Lo Muzio L. Int J Oncol; 2007 Apr; 30(4):813-23. PubMed ID: 17332919 [Abstract] [Full Text] [Related]
42. High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA. Weissenborn SJ, Höpfl R, Weber F, Smola H, Pfister HJ, Fuchs PG. J Invest Dermatol; 1999 Jul; 113(1):122-6. PubMed ID: 10417630 [Abstract] [Full Text] [Related]
43. Epidermodysplasia-verruciformis-like eruption associated with gamma-papillomavirus infection in a patient with adult T-cell leukemia. Kawai K, Egawa N, Kiyono T, Kanekura T. Dermatology; 2009 Jul; 219(3):274-8. PubMed ID: 19696474 [Abstract] [Full Text] [Related]
44. Papillomaviruses and skin cancer in Africa. Lutzner MA. IARC Sci Publ; 1984 Jul; (63):607-23. PubMed ID: 6100284 [Abstract] [Full Text] [Related]
45. Psoriasis: A possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. Favre M, Orth G, Majewski S, Baloul S, Pura A, Jablonska S. J Invest Dermatol; 1998 Apr; 110(4):311-7. PubMed ID: 9540967 [Abstract] [Full Text] [Related]
47. Why epidermodysplasia verruciformis - a rare genetic disease - has raised such great interest. Majewski S, Jablonska S. Int J Dermatol; 2004 Apr; 43(4):309-11. PubMed ID: 15090022 [No Abstract] [Full Text] [Related]
48. Epidermodysplasia verruciformis in human immunodeficiency virus-infected patients: a marker of human papillomavirus-related disorders not affected by antiretroviral therapy. Jacobelli S, Laude H, Carlotti A, Rozenberg F, Deleuze J, Morini JP, Franck N, Gorin I, Avril MF, Dupin N. Arch Dermatol; 2011 May; 147(5):590-6. PubMed ID: 21242344 [Abstract] [Full Text] [Related]
49. Epidermodysplasia verruciformis: a model for understanding the oncogenicity of human papillomaviruses. Orth G. Ciba Found Symp; 1986 May; 120():157-74. PubMed ID: 3013521 [Abstract] [Full Text] [Related]
57. "High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Bouda M, Gorgoulis VG, Kastrinakis NG, Giannoudis A, Tsoli E, Danassi-Afentaki D, Foukas P, Kyroudi A, Laskaris G, Herrington CS, Kittas C. Mod Pathol; 2000 Jun; 13(6):644-53. PubMed ID: 10874669 [Abstract] [Full Text] [Related]
59. A mouse model for studying epidermodysplasia-verruciformis-associated carcinogenesis. Majewski S, Breitburd F, Skopinska M, Croissant O, Jablonska S, Orth G. Int J Cancer; 1994 Mar 01; 56(5):727-30. PubMed ID: 8314350 [Abstract] [Full Text] [Related]